Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States

BACKGROUND: Expanding statin use may help to alleviate the excess burden of atherosclerotic cardiovascular disease in people living with HIV (PLHIV). Pravastatin and pitavastatin are preferred agents due to their lack of substantial interaction with antiretroviral therapy. We aimed to evaluate the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Boettiger, David C, Newall, Anthony T, Phillips, Andrew, Bendavid, Eran, Law, Matthew G, Ryom, Lene, Reiss, Peter, Mocroft, Amanda, Bonnet, Fabrice, Weber, Rainer, El‐Sadr, Wafaa, d’Arminio Monforte, Antonella, de Wit, Stephane, Pradier, Christian, Hatleberg, Camilla I, Lundgren, Jens, Sabin, Caroline, Kahn, James G, Kazi, Dhruv S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982504/
https://www.ncbi.nlm.nih.gov/pubmed/33749164
http://dx.doi.org/10.1002/jia2.25690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982504/
https://www.ncbi.nlm.nih.gov/pubmed/33749164
http://dx.doi.org/10.1002/jia2.25690

Ejemplares similares